Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06872502
Active, not recruiting Not applicable

Meditation and Psychophysical Well-Being in Elderly

NCT06872502 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-02-15
Last updated
2026-08-11

Condition(s) studied

LonelinessPsychophysical Well-being

Investigational drug(s) / intervention(s)

Mindfulness-Based Meditation (Integral Meditation - IM)

Mindfulness-Based Meditation (Integral Meditation - IM): The intervention consists of 12 in-person mindfulness-based meditation sessions over a period of six weeks, with each session lasting one hour, twice per week. The practice, called Integral Meditation (IM), includes focused breathing, body relaxation, emotional awareness, and acceptance exercises.

Study summary

The goal of this experimental study is to assess whether a mindfulness-based meditation intervention can reduce loneliness and improve psychophysical well-being in older adults (aged 65 and above).

The main questions it aims to answer are:

* Does the intervention reduce the perception of loneliness in older adults? (primary outcome)
* Does it improve various aspects of psychological well-being, including social isolation, depression, life satisfaction, mindfulness, emotional regulation, self-acceptance, and sleep quality? (secondary outcomes) Researchers will compare the intervention group with a passive control group (waiting-list control) to determine whether the mindfulness-based intervention leads to significant improvements in the measured outcomes.

Participants will:

Complete baseline assessments, including neuropsychological tests and validated questionnaires, before the intervention.

Undergo a 12-session mindfulness-based intervention over 6 weeks, consisting of guided breathing, focused attention, physical relaxation, and emotional awareness exercises.

Complete post-intervention assessments to measure changes in their psychological and physiological well-being.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Understanding of the Italian language * Age ≥ 65 years * No cognitive impairment, as measured by the Addenbrooke's Cognitive Examination (ACE-R) Exclusion Criteria: * Presence of severe mental disorders and/or significant medical conditions * Substance dependence

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Pavia Pavia Italy

More University of Pavia trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06872502 on ClinicalTrials.gov ↗ ← All trials in Italy